(Q44542547)

English

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis (English)

1 reference

Europe PubMed Central

4 December 2017

Mycobacterium tuberculosis

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

4 December 2017

author name string

Jeon BY

2

1 reference

Europe PubMed Central

4 December 2017

Kim SC

3

1 reference

Europe PubMed Central

4 December 2017

Kim DJ

4

1 reference

Europe PubMed Central

4 December 2017

Song MK

5

1 reference

Europe PubMed Central

4 December 2017

Sung YC

6

1 reference

Europe PubMed Central

4 December 2017

Cho SN

7

1 reference

Europe PubMed Central

4 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2003

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

18

1 reference

Europe PubMed Central

4 December 2017

1592-1599

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302057

0 references

Global burden of disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

The action of antituberculosis drugs in short-course chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

TB vaccines: progress and problems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

An antimicrobial activity of cytolytic T cells mediated by granulysin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Vaccination against tuberculosis by DNA injection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Protection against tuberculosis by a plasmid DNA vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Immune effects and mechanisms of action of CpG motifs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Interleukin-12 primes CD4+ T cells for interferon-gamma production and protective immunity during Mycobacterium avium infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Approaches to combat tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

21 January 2018

Immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of immunocompetence in tuberculosis by DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

7 January 2021

based on heuristic

inferred from DOI database lookup

Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302057

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302057

1 reference

Europe PubMed Central

4 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44542547&oldid=2139456571"